NCT01766063View on ClinicalTrials.gov

Investigating the Relationship Between Sleep, Quality of Life,Other Disorders and Therapies in MS Patients on Betaferon

CompletedOBSERVATIONAL
Enrollment

138

Participants

Timeline

Start Date

December 6, 2012

Primary Completion Date

January 9, 2017

Study Completion Date

March 14, 2017

Conditions
Multiple Sclerosis
Interventions
DRUG

Interferon beta-1b (Betaferon, BAY 86-5046)

Patients will be followed-up for 24 months

Trial Locations (1)

Unknown

Multiple Locations

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY